Improved Stock Price Performance of HealthCare Related Companies - Research Report on Omega, BioScrip, Accuray, Stereotaxis and

 Improved Stock Price Performance of HealthCare Related Companies - Research
  Report on Omega, BioScrip, Accuray, Stereotaxis and Sagent Pharmaceuticals

Editor Note: For more information about this release, please scroll to bottom.

PR Newswire

NEW YORK, December 20, 2013

NEW YORK, December 20, 2013 /PRNewswire/ --

Today, Analysts' Corner announced new research reports highlighting Omega
Healthcare Investors Inc. (NYSE: OHI), BioScrip Inc. (NASDAQ: BIOS), Accuray
Incorporated (NASDAQ: ARAY), Stereotaxis Inc. (NASDAQ: STXS), and Sagent
Pharmaceuticals, Inc. (NASDAQ: SGNT). Today's readers may access these reports
free of charge - including full price targets, industry analysis and analyst
ratings - via the links below.

Omega Healthcare Investors Inc. Research Report

On December 17, 2013, Omega Healthcare Investors Inc.'s (Omega) stock
reflected an increase of 1.48% as it closed the day at $30.23 per share. For
the past three trading day period, the Company' stock gained 0.37%, slightly
lower as compared to the Dow Jones Industrial Average which increased by 0.86%
over the same three day trading period. The Full Research Report on Omega
Healthcare Investors Inc. - including full detailed breakdown, analyst ratings
and price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/063c_OHI

--

BioScrip Inc. Research Report

On December 17, 2013, BioScrip Inc.'s (BioScrip) stock increased significantly
by 8.87%, closing the day at $7.12 per share. Over the previous three day
trading period, the Company's stock went up by 8.36%, beating the Nasdaq
composite which gained 0.63%, during the same three day trading period. The
Full Research Report on BioScrip Inc. - including full detailed breakdown,
analyst ratings and price targets - is available to download free of charge
at:

http://www.analystscorner.com/r/full_research_report/4879_BIOS

--

Accuray Incorporated Research Report

On December 17, 2013, Accuray Incorporated's (Accuray) stock closed the day at
$8.41 per share, reflecting a 2.94% increase over the previous day's closing
price. The Company's stock went up by 7.0% over the past three day trading
period, compared to the Dow Jones Industrial Average which went up by 0.86%
during the same three day trading session. The Full Research Report on Accuray
Incorporated - including full detailed breakdown, analyst ratings and price
targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/36bf_ARAY

--

Stereotaxis Inc. Research Report

On December 17, 2013, Stereotaxis Inc.'s (Stereotaxis) stock reflected a
massive increase of 10.98%, to close the day at $3.64 per share. For the past
three trading day period, the Company's shares increased 14.83%, compared to
the S&P 500 which went up by 0.31% during the same three day trading session.
The Full Research Report on Stereotaxis Inc. - including full detailed
breakdown, analyst ratings and price targets - is available to download free
of charge at:

http://www.analystscorner.com/r/full_research_report/b071_STXS

--

Sagent Pharmaceuticals, Inc. Research Report

On December 17, 2013, Sagent Pharmaceuticals, Inc.'s (Sagent Pharmaceuticals)
stock went up by 1.92%, closing the day at $23.93 per share. Over the previous
three day trading session, Sagent Pharmaceuticals' stock reflected an increase
of 6.07%, compared to the Dow Jones Industrial Average which went up by 0.86%,
and the Nasdaq composite which went up by 0.63%, during the same three day
trading period. The Full Research Report on Sagent Pharmaceuticals, Inc. -
including full detailed breakdown, analyst ratings and price targets - is
available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/a901_SGNT

----

EDITOR NOTES:

1.This is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
    basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are
    only human and are prone to make mistakes. If you notice any errors or
    omissions, please notify us below.
3.This information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
4.If you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at
    pubco@EquityNewsNetwork.com.
5.For any urgent concerns or inquiries, please contact us at
    compliance@EquityNewsNetwork.com.
6.Are you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to
    research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider represented by Ananya Ghosh, CFA, has
only reviewed the information provided by Equity News Network in this article
or report according to the Procedures outlined by Equity News Network. Equity
News Network is not entitled to veto or interfere in the application of such
procedures by the outsourced provider to the articles, documents or reports,
as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA
Institute.

http://AnalystsCorner.com



SOURCE Analysts' Corner

Contact: CONTACT PERSON: Joe Thomas CONTACT PHONE: +1-310-496-8071 (North
America)
 
Press spacebar to pause and continue. Press esc to stop.